Spencer Pharmaceutical Stock Net Income
| SPPH Stock | USD 0.0001 0.00 0.000003% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Spencer Pharmaceutical's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Net Loss | -848.9 K | -806.4 K | |
| Net Loss | -848.9 K | -806.4 K | |
| Net Loss | -848.9 K | -806.4 K | |
| Net Loss | (0.99) | (1.04) | |
| Net Income Per E B T | 1.14 | 1.10 |
Spencer | Net Income | Build AI portfolio with Spencer Stock |
Spencer Pharmaceutical Company Net Income Analysis
Spencer Pharmaceutical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Spencer Pharmaceutical Net Income | (943.2 K) |
Most of Spencer Pharmaceutical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Spencer Pharmaceutical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Spencer Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Spencer Pharmaceutical is extremely important. It helps to project a fair market value of Spencer Stock properly, considering its historical fundamentals such as Net Income. Since Spencer Pharmaceutical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Spencer Pharmaceutical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Spencer Pharmaceutical's interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, Spencer Pharmaceutical reported net income of (943,196). This is 100.28% lower than that of the Healthcare sector and 101.35% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.17% higher than that of the company.
Spencer Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Spencer Pharmaceutical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Spencer Pharmaceutical could also be used in its relative valuation, which is a method of valuing Spencer Pharmaceutical by comparing valuation metrics of similar companies.Spencer Pharmaceutical is currently under evaluation in net income category among its peers.
Spencer Fundamentals
| Return On Asset | -1.42 | ||||
| Current Valuation | 1.18 M | ||||
| Price To Book | 0.35 X | ||||
| Net Income | (943.2 K) | ||||
| Cash And Equivalents | 455.93 K | ||||
| Total Debt | 2.91 M | ||||
| Current Ratio | 0.28 X | ||||
| Book Value Per Share | (0) X | ||||
| Cash Flow From Operations | 642.43 K | ||||
| Beta | 34.99 | ||||
| Market Capitalization | 1.34 M | ||||
| Total Asset | 772.2 K | ||||
| Net Asset | 772.2 K |
About Spencer Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Spencer Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Spencer Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Spencer Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out Spencer Pharmaceutical Piotroski F Score and Spencer Pharmaceutical Altman Z Score analysis. For more detail on how to invest in Spencer Stock please use our How to Invest in Spencer Pharmaceutical guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spencer Pharmaceutical. If investors know Spencer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spencer Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Spencer Pharmaceutical is measured differently than its book value, which is the value of Spencer that is recorded on the company's balance sheet. Investors also form their own opinion of Spencer Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Spencer Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spencer Pharmaceutical's market value can be influenced by many factors that don't directly affect Spencer Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spencer Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Spencer Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spencer Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.